Stock COYA COYA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Coya Therapeutics, Inc.

Equities

COYA

US22407B1089

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
7.19 USD +3.01% Intraday chart for Coya Therapeutics, Inc. -5.64% -2.97%
May. 22 Coya Therapeutics Announces the Completion of a Controlled Phase 2 Study of Low Dose Interleukin-2 (LD IL-2) in Patients with Alzheimer's Disease CI
May. 20 Coya Therapeutics Receives $5 Million Equity Investment from Alzheimer's Drug Discovery Foundation MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Chardan Ups PT on Coya Therapeutics to $14 From $11 on Advancements of COYA 302 Targeting Multiple Neurodegenerative Diseases, Keeps Buy Rating
MT
Chardan Ups Price Target on Coya Therapeutics to $11 From $9 as Additional Data from Open-Label Study COYA 301 Emerges; Keeps Buy Rating
MT
BTIG Starts Coya Therapeutics at Buy With $15 Price Target
MT
EF Hutton Initiates Coya Therapeutics at Buy With $28 Price Target
MT
Chardan Starts Coya Therapeutics at Buy With $9 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. COYA Stock
  4. News Coya Therapeutics, Inc.
  5. Analyst Reco.